Global Personalized Medicines In Oncology Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Personalized Medicines In Oncology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Molecular Oncopathology
  • 1.2.3 Genome Diagnostics
  • 1.2.4 Radiation Therapy
  • 1.2.5 Oncology Testing
  • 1.2.6 Chemotherapy
  • 1.2.7 Others
• 1.3 Market by Application
  • 1.3.1 Global Personalized Medicines In Oncology Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Research Centers
  • 1.3.3 Governmental Institutions
  • 1.3.4 Hospitals
  • 1.3.5 Clinical Centers
  • 1.3.6 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Personalized Medicines In Oncology Market Perspective (2016-2027)
• 2.2 Personalized Medicines In Oncology Growth Trends by Regions
  • 2.2.1 Personalized Medicines In Oncology Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Personalized Medicines In Oncology Historic Market Share by Regions (2016-2021)
  • 2.2.3 Personalized Medicines In Oncology Forecasted Market Size by Regions (2022-2027)
• 2.3 Personalized Medicines In Oncology Industry Dynamic
  • 2.3.1 Personalized Medicines In Oncology Market Trends
  • 2.3.2 Personalized Medicines In Oncology Market Drivers
  • 2.3.3 Personalized Medicines In Oncology Market Challenges
  • 2.3.4 Personalized Medicines In Oncology Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Personalized Medicines In Oncology Players by Revenue
  • 3.1.1 Global Top Personalized Medicines In Oncology Players by Revenue (2016-2021)
  • 3.1.2 Global Personalized Medicines In Oncology Revenue Market Share by Players (2016-2021)
• 3.2 Global Personalized Medicines In Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Personalized Medicines In Oncology Revenue
• 3.4 Global Personalized Medicines In Oncology Market Concentration Ratio
  • 3.4.1 Global Personalized Medicines In Oncology Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicines In Oncology Revenue in 2020
• 3.5 Personalized Medicines In Oncology Key Players Head office and Area Served
• 3.6 Key Players Personalized Medicines In Oncology Product Solution and Service
• 3.7 Date of Enter into Personalized Medicines In Oncology Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Personalized Medicines In Oncology Breakdown Data by Type

• 4.1 Global Personalized Medicines In Oncology Historic Market Size by Type (2016-2021)
• 4.2 Global Personalized Medicines In Oncology Forecasted Market Size by Type (2022-2027)

5 Personalized Medicines In Oncology Breakdown Data by Application

• 5.1 Global Personalized Medicines In Oncology Historic Market Size by Application (2016-2021)
• 5.2 Global Personalized Medicines In Oncology Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Personalized Medicines In Oncology Market Size (2016-2027)
• 6.2 North America Personalized Medicines In Oncology Market Size by Type
  • 6.2.1 North America Personalized Medicines In Oncology Market Size by Type (2016-2021)
  • 6.2.2 North America Personalized Medicines In Oncology Market Size by Type (2022-2027)
  • 6.2.3 North America Personalized Medicines In Oncology Market Size by Type (2016-2027)
• 6.3 North America Personalized Medicines In Oncology Market Size by Application
  • 6.3.1 North America Personalized Medicines In Oncology Market Size by Application (2016-2021)
  • 6.3.2 North America Personalized Medicines In Oncology Market Size by Application (2022-2027)
  • 6.3.3 North America Personalized Medicines In Oncology Market Size by Application (2016-2027)
• 6.4 North America Personalized Medicines In Oncology Market Size by Country
  • 6.4.1 North America Personalized Medicines In Oncology Market Size by Country (2016-2021)
  • 6.4.2 North America Personalized Medicines In Oncology Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Personalized Medicines In Oncology Market Size (2016-2027)
• 7.2 Europe Personalized Medicines In Oncology Market Size by Type
  • 7.2.1 Europe Personalized Medicines In Oncology Market Size by Type (2016-2021)
  • 7.2.2 Europe Personalized Medicines In Oncology Market Size by Type (2022-2027)
  • 7.2.3 Europe Personalized Medicines In Oncology Market Size by Type (2016-2027)
• 7.3 Europe Personalized Medicines In Oncology Market Size by Application
  • 7.3.1 Europe Personalized Medicines In Oncology Market Size by Application (2016-2021)
  • 7.3.2 Europe Personalized Medicines In Oncology Market Size by Application (2022-2027)
  • 7.3.3 Europe Personalized Medicines In Oncology Market Size by Application (2016-2027)
• 7.4 Europe Personalized Medicines In Oncology Market Size by Country
  • 7.4.1 Europe Personalized Medicines In Oncology Market Size by Country (2016-2021)
  • 7.4.2 Europe Personalized Medicines In Oncology Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Personalized Medicines In Oncology Market Size (2016-2027)
• 8.2 Asia-Pacific Personalized Medicines In Oncology Market Size by Type
  • 8.2.1 Asia-Pacific Personalized Medicines In Oncology Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Personalized Medicines In Oncology Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Personalized Medicines In Oncology Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Personalized Medicines In Oncology Market Size by Application
  • 8.3.1 Asia-Pacific Personalized Medicines In Oncology Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Personalized Medicines In Oncology Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Personalized Medicines In Oncology Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Personalized Medicines In Oncology Market Size by Region
  • 8.4.1 Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Personalized Medicines In Oncology Market Size (2016-2027)
• 9.2 Latin America Personalized Medicines In Oncology Market Size by Type
  • 9.2.1 Latin America Personalized Medicines In Oncology Market Size by Type (2016-2021)
  • 9.2.2 Latin America Personalized Medicines In Oncology Market Size by Type (2022-2027)
  • 9.2.3 Latin America Personalized Medicines In Oncology Market Size by Type (2016-2027)
• 9.3 Latin America Personalized Medicines In Oncology Market Size by Application
  • 9.3.1 Latin America Personalized Medicines In Oncology Market Size by Application (2016-2021)
  • 9.3.2 Latin America Personalized Medicines In Oncology Market Size by Application (2022-2027)
  • 9.3.3 Latin America Personalized Medicines In Oncology Market Size by Application (2016-2027)
• 9.4 Latin America Personalized Medicines In Oncology Market Size by Country
  • 9.4.1 Latin America Personalized Medicines In Oncology Market Size by Country (2016-2021)
  • 9.4.2 Latin America Personalized Medicines In Oncology Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Personalized Medicines In Oncology Market Size (2016-2027)
• 10.2 Middle East & Africa Personalized Medicines In Oncology Market Size by Type
  • 10.2.1 Middle East & Africa Personalized Medicines In Oncology Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Personalized Medicines In Oncology Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Personalized Medicines In Oncology Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Personalized Medicines In Oncology Market Size by Application
  • 10.3.1 Middle East & Africa Personalized Medicines In Oncology Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Personalized Medicines In Oncology Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Personalized Medicines In Oncology Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Personalized Medicines In Oncology Market Size by Country
  • 10.4.1 Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Biotheranostics
  • 11.1.1 Biotheranostics Company Details
  • 11.1.2 Biotheranostics Business Overview
  • 11.1.3 Biotheranostics Personalized Medicines In Oncology Introduction
  • 11.1.4 Biotheranostics Revenue in Personalized Medicines In Oncology Business (2016-2021)
  • 11.1.5 Biotheranostics Recent Development
• 11.2 Illumina
  • 11.2.1 Illumina Company Details
  • 11.2.2 Illumina Business Overview
  • 11.2.3 Illumina Personalized Medicines In Oncology Introduction
  • 11.2.4 Illumina Revenue in Personalized Medicines In Oncology Business (2016-2021)
  • 11.2.5 Illumina Recent Development
• 11.3 DNA Link
  • 11.3.1 DNA Link Company Details
  • 11.3.2 DNA Link Business Overview
  • 11.3.3 DNA Link Personalized Medicines In Oncology Introduction
  • 11.3.4 DNA Link Revenue in Personalized Medicines In Oncology Business (2016-2021)
  • 11.3.5 DNA Link Recent Development
• 11.4 Genomic Health, Inc.(Exact Sciences)
  • 11.4.1 Genomic Health, Inc.(Exact Sciences) Company Details
  • 11.4.2 Genomic Health, Inc.(Exact Sciences) Business Overview
  • 11.4.3 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Introduction
  • 11.4.4 Genomic Health, Inc.(Exact Sciences) Revenue in Personalized Medicines In Oncology Business (2016-2021)
  • 11.4.5 Genomic Health, Inc.(Exact Sciences) Recent Development
• 11.5 Cypher Genomics(Human Longevity, Inc.)
  • 11.5.1 Cypher Genomics(Human Longevity, Inc.) Company Details
  • 11.5.2 Cypher Genomics(Human Longevity, Inc.) Business Overview
  • 11.5.3 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Introduction
  • 11.5.4 Cypher Genomics(Human Longevity, Inc.) Revenue in Personalized Medicines In Oncology Business (2016-2021)
  • 11.5.5 Cypher Genomics(Human Longevity, Inc.) Recent Development
• 11.6 Life Technologies Corporation(Thermo Fisher Scientific)
  • 11.6.1 Life Technologies Corporation(Thermo Fisher Scientific) Company Details
  • 11.6.2 Life Technologies Corporation(Thermo Fisher Scientific) Business Overview
  • 11.6.3 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Introduction
  • 11.6.4 Life Technologies Corporation(Thermo Fisher Scientific) Revenue in Personalized Medicines In Oncology Business (2016-2021)
  • 11.6.5 Life Technologies Corporation(Thermo Fisher Scientific) Recent Development
• 11.7 Fulgent Genetics
  • 11.7.1 Fulgent Genetics Company Details
  • 11.7.2 Fulgent Genetics Business Overview
  • 11.7.3 Fulgent Genetics Personalized Medicines In Oncology Introduction
  • 11.7.4 Fulgent Genetics Revenue in Personalized Medicines In Oncology Business (2016-2021)
  • 11.7.5 Fulgent Genetics Recent Development
• 11.8 Caris Life Sciences
  • 11.8.1 Caris Life Sciences Company Details
  • 11.8.2 Caris Life Sciences Business Overview
  • 11.8.3 Caris Life Sciences Personalized Medicines In Oncology Introduction
  • 11.8.4 Caris Life Sciences Revenue in Personalized Medicines In Oncology Business (2016-2021)
  • 11.8.5 Caris Life Sciences Recent Development
• 11.9 Ariana Pharma
  • 11.9.1 Ariana Pharma Company Details
  • 11.9.2 Ariana Pharma Business Overview
  • 11.9.3 Ariana Pharma Personalized Medicines In Oncology Introduction
  • 11.9.4 Ariana Pharma Revenue in Personalized Medicines In Oncology Business (2016-2021)
  • 11.9.5 Ariana Pharma Recent Development
• 11.10 Abbott Laboratories
  • 11.10.1 Abbott Laboratories Company Details
  • 11.10.2 Abbott Laboratories Business Overview
  • 11.10.3 Abbott Laboratories Personalized Medicines In Oncology Introduction
  • 11.10.4 Abbott Laboratories Revenue in Personalized Medicines In Oncology Business (2016-2021)
  • 11.10.5 Abbott Laboratories Recent Development
• 11.11 deCODE genetics
  • 11.11.1 deCODE genetics Company Details
  • 11.11.2 deCODE genetics Business Overview
  • 11.11.3 deCODE genetics Personalized Medicines In Oncology Introduction
  • 11.11.4 deCODE genetics Revenue in Personalized Medicines In Oncology Business (2016-2021)
  • 11.11.5 deCODE genetics Recent Development
• 11.12 Exagen Inc
  • 11.12.1 Exagen Inc Company Details
  • 11.12.2 Exagen Inc Business Overview
  • 11.12.3 Exagen Inc Personalized Medicines In Oncology Introduction
  • 11.12.4 Exagen Inc Revenue in Personalized Medicines In Oncology Business (2016-2021)
  • 11.12.5 Exagen Inc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer